Microfluidic platforms for modeling biological barriers in the circulatory system.

Microfluidic platforms have recently become popular as in vitro models because of their superiority in recapitulating microenvironments compared with conventional in vitro models. By providing various biochemical and biomechanical cues, healthy and diseased models at the organ level can be applied to disease progression and treatment studies. Microfluidic technologies are especially suitable for modeling biological barriers because the flow in the microchannels mimics the blood flow and body fluids at the interfaces of crucial organs, such as lung, intestine, liver, kidney, brain, and skin. These barriers have similar structures and can be studied with similar approaches for the testing of pharmaceutical compounds. Here, we review recent developments in microfluidic platforms for modeling biological barriers in the circulatory system.

[1]  Jong Hwan Sung,et al.  A pumpless multi‐organ‐on‐a‐chip (MOC) combined with a pharmacokinetic–pharmacodynamic (PK–PD) model , 2017, Biotechnology and bioengineering.

[2]  A. Manz,et al.  Lab-on-a-chip: microfluidics in drug discovery , 2006, Nature Reviews Drug Discovery.

[3]  Cheng-Hsien Liu,et al.  A biologically inspired lung-on-a-chip device for the study of protein-induced lung inflammation. , 2015, Integrative biology : quantitative biosciences from nano to macro.

[4]  S. Perrin.  Preclinical research: Make mouse studies work , 2014, Nature.

[5]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[6]  I. Cuthill,et al.  Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines , 2010, British journal of pharmacology.

[7]  Hanry Yu,et al.  Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments. , 2009, Lab on a chip.

[8]  P. Romagnani,et al.  Modeling the Glomerular Filtration Barrier: Are You Kidney-ing Me? , 2017, Cell stem cell.

[9]  S. Hogan,et al.  Intestinal barrier function: molecular regulation and disease pathogenesis. , 2009, The Journal of allergy and clinical immunology.

[10]  D. Hackam,et al.  Translating animal research into clinical benefit , 2007, BMJ : British Medical Journal.

[11]  Nupura S. Bhise,et al.  A liver-on-a-chip platform with bioprinted hepatic spheroids , 2016, Biofabrication.

[12]  Gretchen J. Mahler,et al.  A novel microfluidic device to model the human proximal tubule and glomerulus , 2017 .

[13]  J. Brandner,et al.  The skin: an indispensable barrier , 2008, Experimental dermatology.

[14]  R. Booth,et al.  A multiple-channel, multiple-assay platform for characterization of full-range shear stress effects on vascular endothelial cells. , 2014, Lab on a chip.

[15]  J. Collins,et al.  Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip , 2015, Proceedings of the National Academy of Sciences.

[16]  Yuki Imura,et al.  A Microfluidic System to Evaluate Intestinal Absorption , 2009, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[17]  J. Capadona,et al.  In vitro evaluation and in vivo demonstration of a biomimetic, hemocompatible, microfluidic artificial lung. , 2015, Lab on a chip.

[18]  D. Ingber,et al.  Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. , 2012, Lab on a chip.

[19]  Donald E Ingber,et al.  Microengineered physiological biomimicry: organs-on-chips. , 2012, Lab on a chip.

[20]  N. Shanks,et al.  Are animal models predictive for humans? , 2009, Philosophy, ethics, and humanities in medicine : PEHM.

[21]  Alon Friedman,et al.  Overview and introduction: The blood–brain barrier in health and disease , 2012, Epilepsia.

[22]  J. Turner,et al.  Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease , 2015, Mucosal Immunology.

[23]  P. Chuang,et al.  The Glomerular Filtration Barrier: Components and Crosstalk , 2012, International journal of nephrology.

[24]  Thomas C. Ferrante,et al.  Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro , 2015, Nature Methods.

[25]  D. Ingber,et al.  Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.

[26]  J. Garlick,et al.  Three‐Dimensional Tissue Models of Normal and Diseased Skin , 2008, Current protocols in cell biology.

[27]  Thomas Geiser,et al.  A lung-on-a-chip array with an integrated bio-inspired respiration mechanism. , 2015, Lab on a chip.

[28]  Kyung-Jin Jang,et al.  Fluid-shear-stress-induced translocation of aquaporin-2 and reorganization of actin cytoskeleton in renal tubular epithelial cells. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[29]  J. Krueger,et al.  Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications. , 2014, The journal of allergy and clinical immunology. In practice.

[30]  James C. Weaver,et al.  Human Gut-On-A-Chip Supports Polarized Infection of Coxsackie B1 Virus In Vitro , 2017, PloS one.

[31]  Yue Yu,et al.  A disease model of diabetic nephropathy in a glomerulus-on-a-chip microdevice. , 2017, Lab on a chip.

[32]  R. Daneman,et al.  The blood-brain barrier. , 2015, Cold Spring Harbor perspectives in biology.

[33]  N. Abbott.  Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models. , 2004, Drug discovery today. Technologies.

[34]  I. Shelef,et al.  Anatomy and physiology of the blood-brain barrier. , 2015, Seminars in cell & developmental biology.

[35]  G. Goldstein,et al.  Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries. , 1978, Science.

[36]  V. K. Rai,et al.  Efficient Hepatic Delivery of Drugs: Novel Strategies and Their Significance , 2013, BioMed research international.

[37]  S. Jacob,et al.  Frequency of contact allergens in pediatric patients with atopic dermatitis. , 2011, The Journal of clinical and aesthetic dermatology.

[38]  M. Shuler,et al.  Microfluidic blood–brain barrier model provides in vivo‐like barrier properties for drug permeability screening , 2017, Biotechnology and bioengineering.

[39]  Michael L. Shuler,et al.  Modeling Barrier Tissues In Vitro: Methods, Achievements, and Challenges , 2016, EBioMedicine.

[40]  L. Fonacier,et al.  The role of contact allergy in atopic dermatitis. , 2010, Immunology and allergy clinics of North America.

[41]  P. Somasundaran,et al.  Effect of mixed surfactants on stratum corneum: a drying stress and Raman spectroscopy study , 2014, International journal of cosmetic science.

[42]  Scott H Randell,et al.  Well-differentiated human airway epithelial cell cultures. , 2005, Methods in molecular medicine.

[43]  Jason R Spence,et al.  Organoid Models of Human Gastrointestinal Development and Disease. , 2016, Gastroenterology.

[44]  N. Sawada,et al.  血液‐胆管バリアの調節:肝細胞でのギャップ結合と密着結合の相互作用 , 2003 .

[45]  R. Wolf,et al.  Structure and function of the epidermis related to barrier properties. , 2012, Clinics in dermatology.

[46]  Jing Lin,et al.  The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery. , 2003, Current topics in medicinal chemistry.

[47]  K. Suh,et al.  A multi-layer microfluidic device for efficient culture and analysis of renal tubular cells. , 2010, Lab on a chip.

[48]  Joan E Nichols,et al.  Novel in vitro respiratory models to study lung development, physiology, pathology and toxicology , 2013, Stem Cell Research & Therapy.

[49]  D. Ingber,et al.  Microfluidic organs-on-chips , 2014, Nature Biotechnology.

[50]  Mandy B. Esch,et al.  Modular, pumpless body-on-a-chip platform for the co-culture of GI tract epithelium and 3D primary liver tissue. , 2016, Lab on a chip.

[51]  R. Rodríguez-Roisín.  Acute severe asthma: pathophysiology and pathobiology of gas exchange abnormalities. , 1997, The European respiratory journal.

[52]  Ken Arai,et al.  Three-Dimensional Blood-Brain Barrier Model for in vitro Studies of Neurovascular Pathology , 2015, Scientific Reports.

[53]  Manjunath Hegde,et al.  Long-term maintenance of a microfluidic 3D human liver sinusoid. , 2016, Biotechnology and bioengineering.

[54]  Gwo-Bin Lee,et al.  Microfluidic cell culture systems for drug research. , 2010, Lab on a chip.

[55]  Adam S. Hayward,et al.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME , 2013, Archives of Toxicology.

[56]  M. Matthay,et al.  Regulation and repair of the alveolar-capillary barrier in acute lung injury. , 2013, Annual review of physiology.

[57]  Lihong Liu,et al.  Modern methods for delivery of drugs across the blood-brain barrier. , 2012, Advanced drug delivery reviews.

[58]  Byung Jun Kim,et al.  Skin-on-a-chip model simulating inflammation, edema and drug-based treatment , 2016, Scientific Reports.

[59]  R. Sutton,et al.  A mouse model of pathological small intestinal epithelial cell apoptosis and shedding induced by systemic administration of lipopolysaccharide , 2013, Disease Models & Mechanisms.

[60]  Joe Tien,et al.  Formation of perfused, functional microvascular tubes in vitro. , 2006, Microvascular research.

[61]  S. Liebner,et al.  Current concepts of blood-brain barrier development. , 2011, The International journal of developmental biology.

[62]  Ali Khademhosseini,et al.  Organ-on-a-chip platforms for studying drug delivery systems. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[63]  K. Makino,et al.  Skin permeability and transdermal delivery route of 50-nm indomethacin-loaded PLGA nanoparticles. , 2017, Colloids and surfaces. B, Biointerfaces.

[64]  W. Pardridge.  The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.

[65]  K. Madison,et al.  Barrier function of the skin: "la raison d'être" of the epidermis. , 2003, The Journal of investigative dermatology.

[66]  Melvin E. Andersen,et al.  Organotypic liver culture models: Meeting current challenges in toxicity testing , 2012, Critical reviews in toxicology.

[67]  N. LaRusso,et al.  The dynamic biliary epithelia: molecules, pathways, and disease. , 2013, Journal of hepatology.

[68]  R. Kamm,et al.  Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function , 2012, Proceedings of the National Academy of Sciences.

[69]  A. Berg,et al.  BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function , 2013, Biomedical microdevices.

[70]  T. Merchant,et al.  Radiation-induced permeability and leukocyte adhesion in the rat blood–brain barrier: modulation with anti-ICAM-1 antibodies , 2003, Brain Research.

[71]  Donald E. Ingber,et al.  Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip , 2016, PloS one.

[72]  Sjoerd Post,et al.  The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system , 2014, Immunological reviews.

[73]  C. Ehrhardt,et al.  In Vitro Models of the Alveolar Epithelial Barrier , 2008 .

[74]  D. Hay,et al.  Polarisation and functional characterisation of hepatocytes derived from human embryonic and mesenchymal stem cells. , 2015, Biomedical reports.

[75]  J. Prakash,et al.  Drug targeting to the diseased liver. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[76]  W. Strober,et al.  Experimental Models of Inflammatory Bowel Diseases , 2015, Cellular and molecular gastroenterology and hepatology.

[77]  Feng Liu,et al.  A highly efficient synthetic vector: nonhydrodynamic delivery of DNA to hepatocyte nuclei in vivo. , 2013, ACS nano.

[78]  S. Reinhardt,et al.  A Novel Blood-Brain Barrier Co-Culture System for Drug Targeting of Alzheimer’s Disease: Establishment by Using Acitretin as a Model Drug , 2014, PloS one.

[79]  R. Glenny,et al.  Gas exchange and ventilation–perfusion relationships in the lung , 2014, European Respiratory Journal.

[80]  Paul Vulto,et al.  Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening. , 2016, Trends in biotechnology.

[81]  Chenghua Gu,et al.  The Molecular Constituents of the Blood–Brain Barrier , 2015, Trends in Neurosciences.

[82]  A. Blikslager,et al.  Restoration of barrier function in injured intestinal mucosa. , 2007, Physiological reviews.

[83]  D. de Zeeuw,et al.  Specific Drug Delivery to the Kidney , 2002, Cardiovascular Drugs and Therapy.

[84]  S. Quaggin,et al.  The cell biology of renal filtration , 2015, The Journal of cell biology.

[85]  Manjunath Hegde,et al.  In vitro platforms for evaluating liver toxicity , 2014, Experimental biology and medicine.

[86]  D. Huh,et al.  Organs-on-chips at the frontiers of drug discovery , 2015, Nature Reviews Drug Discovery.

[87]  V. Teichberg.  From the liver to the brain across the blood–brain barrier , 2007, Proceedings of the National Academy of Sciences.

[88]  Jeremy D Caplin,et al.  Microfluidic Organ‐on‐a‐Chip Technology for Advancement of Drug Development and Toxicology , 2015, Advanced healthcare materials.

[89]  Lauren Speciner,et al.  Food-associated stimuli enhance barrier properties of gastrointestinal mucus. , 2015, Biomaterials.

[90]  Brendon M. Baker,et al.  Microfluidics embedded within extracellular matrix to define vascular architectures and pattern diffusive gradients. , 2013, Lab on a chip.

[91]  Mohammad F. Kiani,et al.  A Novel Dynamic Neonatal Blood-Brain Barrier on a Chip , 2015, PloS one.

[92]  Shuichi Takayama,et al.  Pharmacokinetic profile that reduces nephrotoxicity of gentamicin in a perfused kidney-on-a-chip , 2016, Biofabrication.

[93]  Hanseup Kim,et al.  Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). , 2012, Lab on a chip.

[94]  Albert van den Berg,et al.  Microfluidic organ-on-chip technology for blood-brain barrier research , 2016, Tissue barriers.

[95]  F. Sonntag,et al.  A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents. , 2015, Lab on a chip.

[96]  Jong Hwan Sung,et al.  Construction of 3D multicellular microfluidic chip for an in vitro skin model , 2017, Biomedical microdevices.

[97]  Mandy B. Esch,et al.  Microfabricated mammalian organ systems and their integration into models of whole animals and humans. , 2013, Lab on a chip.

[98]  J. Guenette,et al.  Pulmonary Gas Exchange Abnormalities in Mild Chronic Obstructive Pulmonary Disease. Implications for Dyspnea and Exercise Intolerance. , 2015, American journal of respiratory and critical care medicine.

[99]  N. Mirancea,et al.  Basement membranes in skin: unique matrix structures with diverse functions? , 2009, Histochemistry and Cell Biology.

[100]  Barbara Rothen-Rutishauser,et al.  Engineering an in vitro air-blood barrier by 3D bioprinting , 2015, Scientific Reports.

[101]  D. Howells,et al.  Can Animal Models of Disease Reliably Inform Human Studies? , 2010, PLoS medicine.

[102]  Luca Cucullo,et al.  In vitro blood-brain barrier models: current and perspective technologies. , 2012, Journal of pharmaceutical sciences.

[103]  Claus-Michael Lehr,et al.  Carrier interactions with the biological barriers of the lung: advanced in vitro models and challenges for pulmonary drug delivery. , 2014, Advanced drug delivery reviews.

[104]  Matthew Loxham,et al.  Cellular crosstalk between airway epithelial and endothelial cells regulates barrier functions during exposure to double‐stranded RNA , 2017, Immunity, inflammation and disease.

[105]  Masami Niwa,et al.  Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology , 2005, Cellular and Molecular Neurobiology.

[106]  L. Wienkers,et al.  Predicting in vivo drug interactions from in vitro drug discovery data , 2005, Nature Reviews Drug Discovery.

[107]  R. Uwiera,et al.  Animal models to study acute and chronic intestinal inflammation in mammals , 2015, Gut Pathogens.

[108]  A. Fasano,et al.  Innovative strategies for the oral delivery of drugs and peptides. , 1998, Trends in biotechnology.

[109]  Ying Zheng,et al.  In vitro microvessels for the study of angiogenesis and thrombosis , 2012, Proceedings of the National Academy of Sciences.

[110]  Sang-Hoon Lee,et al.  3D liver models on a microplatform: well-defined culture, engineering of liver tissue and liver-on-a-chip. , 2015, Lab on a chip.

[111]  Uwe Marx,et al.  ‘Human-on-a-chip’ Developments: A Translational Cutting-edge Alternative to Systemic Safety Assessment and Efficiency Evaluation of Substances in Laboratory Animals and Man? , 2012, Alternatives to laboratory animals : ATLA.

[112]  S. Georas,et al.  Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. , 2014, The Journal of allergy and clinical immunology.

[113]  R. Scheuplein,et al.  Permeability of the Skin , 1971 .

[114]  N. Abbott.  Blood–brain barrier structure and function and the challenges for CNS drug delivery , 2013, Journal of Inherited Metabolic Disease.

[115]  F. Sonntag,et al.  A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. , 2013, Lab on a chip.

[116]  A. Kostic,et al.  The microbiome in inflammatory bowel disease: current status and the future ahead. , 2014, Gastroenterology.

[117]  Jaakko Patrakka,et al.  Molecular make-up of the glomerular filtration barrier. , 2010, Biochemical and biophysical research communications.

[118]  Heidrun Potschka,et al.  Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach. , 2010, Pharmacology & therapeutics.

[119]  T. Peters,et al.  In vitro determination of small intestinal permeability: demonstration of a persistent defect in patients with coeliac disease. , 1984, Gut.

[120]  M. Alonso.  Nanomedicines for overcoming biological barriers. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[121]  J. Brasch,et al.  Abnormal epidermal barrier in the pathogenesis of contact dermatitis. , 2012, Clinics in dermatology.

[122]  D. Belsito,et al.  Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to surfactants. , 2014, Journal of the American Academy of Dermatology.

[123]  J. Pappenheimer,et al.  Filtration, diffusion and molecular sieving through peripheral capillary membranes; a contribution to the pore theory of capillary permeability. , 1951, The American journal of physiology.

[124]  Niraj K Inamdar,et al.  Microfluidic cell culture models for tissue engineering. , 2011, Current opinion in biotechnology.

[125]  Michael L Shuler,et al.  Pumpless microfluidic platform for drug testing on human skin equivalents. , 2015, Lab on a chip.

[126]  M. Karnovsky,et al.  POROUS SUBSTRUCTURE OF THE GLOMERULAR SLIT DIAPHRAGM IN THE RAT AND MOUSE , 1974, The Journal of cell biology.

[127]  Kirsten Peters,et al.  Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro , 2004, Laboratory Investigation.

[128]  Roger D Kamm,et al.  On-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics , 2017, Nature Protocols.

[129]  N. Sawada,et al.  Regulation of the blood–biliary barrier: interaction between gap and tight junctions in hepatocytes , 2003, Medical Electron Microscopy.